Marco Galimberti, Cassie Overstreet, Priya Gupta, Sarah Beck, Cecilia Dao, Joseph D. Deak, Hang Zhou, Emma C. Johnson, Arpana Agrawal, Murray B. Stein, Daniel F. Levey, Joel Gelernter
{"title":"The genetic relationship between cannabis use disorder, cannabis use and psychiatric disorders","authors":"Marco Galimberti, Cassie Overstreet, Priya Gupta, Sarah Beck, Cecilia Dao, Joseph D. Deak, Hang Zhou, Emma C. Johnson, Arpana Agrawal, Murray B. Stein, Daniel F. Levey, Joel Gelernter","doi":"10.1038/s44220-025-00440-4","DOIUrl":null,"url":null,"abstract":"Increasing prevalence of cannabis use and cannabis use disorder (CanUD) may increase risk for psychiatric disorders. We evaluated the relationships between these cannabis traits and a range of psychiatric traits, running global and local genetic correlations, genomic structural equation modeling, colocalization analyses and Mendelian randomization analyses for causality. Global genetic analyses identified significantly different correlations between CanUD and cannabis use. A variant in strong linkage disequilibrium to one regulating CHRNA2 was significantly shared by CanUD and schizophrenia in colocalization analysis and included in a significant region in local genetic correlations between these traits. A three-factor model from genomic structural equation modeling showed that CanUD and cannabis use partially map together onto a factor with major depressive disorder and ADHD. In terms of causality, CanUD showed bidirectional causal relationships with most tested psychiatric disorders, differently from cannabis use. Increasing use of cannabis can increase rates of psychiatric disorders over time, especially in individuals who progress from cannabis use to CanUD. This genetic study utilizing the newest available GWAS summary statistics provides evidence on the relationship between cannabis use, cannabis use disorder and a range of psychiatric disorders.","PeriodicalId":74247,"journal":{"name":"Nature mental health","volume":"3 6","pages":"700-708"},"PeriodicalIF":8.7000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/s44220-025-00440-4.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature mental health","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44220-025-00440-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Increasing prevalence of cannabis use and cannabis use disorder (CanUD) may increase risk for psychiatric disorders. We evaluated the relationships between these cannabis traits and a range of psychiatric traits, running global and local genetic correlations, genomic structural equation modeling, colocalization analyses and Mendelian randomization analyses for causality. Global genetic analyses identified significantly different correlations between CanUD and cannabis use. A variant in strong linkage disequilibrium to one regulating CHRNA2 was significantly shared by CanUD and schizophrenia in colocalization analysis and included in a significant region in local genetic correlations between these traits. A three-factor model from genomic structural equation modeling showed that CanUD and cannabis use partially map together onto a factor with major depressive disorder and ADHD. In terms of causality, CanUD showed bidirectional causal relationships with most tested psychiatric disorders, differently from cannabis use. Increasing use of cannabis can increase rates of psychiatric disorders over time, especially in individuals who progress from cannabis use to CanUD. This genetic study utilizing the newest available GWAS summary statistics provides evidence on the relationship between cannabis use, cannabis use disorder and a range of psychiatric disorders.